CHOLEDYL SA Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Choledyl Sa, and what generic alternatives are available?
Choledyl Sa is a drug marketed by Warner Chilcott Llc and is included in two NDAs.
The generic ingredient in CHOLEDYL SA is oxtriphylline. There are three drug master file entries for this compound. Additional details are available on the oxtriphylline profile page.
Summary for CHOLEDYL SA
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 171 |
Patent Applications: | 6,959 |
Formulation / Manufacturing: | see details |
DailyMed Link: | CHOLEDYL SA at DailyMed |
US Patents and Regulatory Information for CHOLEDYL SA
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Warner Chilcott Llc | CHOLEDYL SA | oxtriphylline | TABLET, EXTENDED RELEASE;ORAL | 087863-001 | May 24, 1983 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Warner Chilcott Llc | CHOLEDYL SA | oxtriphylline | TABLET, EXTENDED RELEASE;ORAL | 086742-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |